BPC-157: Benefits, Dosing & What to Expect

What Is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a naturally occurring protein found in human gastric juice. It is one of the most widely used peptides in regenerative and functional medicine due to its remarkable healing properties across multiple tissue types — tendons, ligaments, muscle, gut lining, and even nerve tissue.

Proven Benefits

BPC-157 has been studied extensively in animal models and increasingly in clinical settings. Its mechanisms of action are broad, making it one of the most versatile peptides available.

• ✓Accelerates tendon and ligament healing — studies show faster recovery from Achilles, rotator cuff, and MCL injuries
• ✓Gut healing — repairs intestinal lining, reduces inflammation in IBD/IBS, counteracts NSAID-induced gut damage
• ✓Neuroprotective effects — promotes nerve regeneration, may help with traumatic brain injury recovery
• ✓Anti-inflammatory — reduces systemic inflammation through multiple pathways
• ✓Counteracts medication side effects — shown to protect against damage from NSAIDs, alcohol, and certain drugs
• ✓Angiogenesis — promotes new blood vessel formation, improving blood flow to injured areas

Dosing Protocols

BPC-157 dosing depends on the route of administration and the condition being treated. Common protocols range from 250-500mcg per day, split into 1-2 doses.

• ✓Subcutaneous injection: 250-500mcg daily, injected near the injury site when possible
• ✓Oral capsule: 500mcg daily, primarily for gut-related conditions
• ✓Standard cycle: 4-8 weeks, with some protocols extending to 12 weeks
• ✓Stacking: Often combined with TB-500 for enhanced healing (the "Wolverine stack")

Oral vs Injectable

BPC-157 is one of the few peptides that shows activity both orally and via injection. For gut-related conditions (leaky gut, IBS, gastric ulcers), oral administration targets the GI tract directly. For musculoskeletal injuries, subcutaneous injection near the injury site provides more localized effect. Many practitioners use both simultaneously for systemic plus targeted benefit.

Side Effects & Safety

BPC-157 has an exceptionally strong safety profile in published research. No significant side effects have been reported in animal studies even at very high doses. The most commonly reported side effect in clinical use is mild nausea, usually temporary. However, because BPC-157 promotes angiogenesis, it should be avoided by anyone with active cancer or a recent cancer history.

What to Expect Timeline

Most people notice initial effects within 1-2 weeks of starting BPC-157. Gut healing often shows improvement within the first week. Tendon and ligament injuries typically show significant improvement by weeks 3-4. Full protocol effects are usually realized by 6-8 weeks.